Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 167 EP applications Desmond Mark Chapman has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11787481

PENTOSE FERMENTATION BY A RECOMBINANT MICROORGANISM

IPC classification:
C07H 21/04, C12P 19/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11853018

NUCLEIC ACID SAMPLE PREPARATION METHODS AND COMPOSITIONS

IPC classification:
C12P 19/34
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11720696

POLYPEPTIDE INHIBITORS OF VLA4

IPC classification:
C07K 14/54
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12771485

ANTISENSE MODULATION OF PTP1B EXPRESSION

IPC classification:
C07H 21/04, C12N 15/113
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12773736

MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION

IPC classification:
C07H 21/02
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12776385

MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION

IPC classification:
A61P 3/06, A61K 31/7088
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11845186

INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY

IPC classification:
A61P 3/04, A61K 31/137, A61K 31/485
Agent:
Zacco Denmark A/S
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12753889

GH61 GLYCOSIDE HYDROLASE PROTEIN VARIANTS AND COFACTORS THAT ENHANCE GH61 ACTIVITY

IPC classification:
C07H 21/00, C12N 9/42
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12829439

SAMPLE PREPARATION METHODS

IPC classification:
C07H 1/08, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12769209

BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF SUBSTITUTED LACTAMS

IPC classification:
C07K 14/435
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12834215

ANTISENSE MODULATION OF GCGR EXPRESSION

IPC classification:
A61P 3/08, A61P 3/10, A61P 7/12, C12N 15/113
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12833556

ENDOGLUCANASE 1B

IPC classification:
C12N 1/15, C12N 1/19, C12N 9/42, C12N 15/56, C12P 19/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11754012

PRODUCTION OF SINGLE-STRANDED CIRCULAR NUCLEIC ACID

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/66, C12P 19/34, C40B 40/08, C40B 50/06
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12843053

ANTISENSE MODULATION OF GCCR EXPRESSION

IPC classification:
C07H 21/04, C12N 5/00, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11766750

MODULATION OF CETP EXPRESSION

IPC classification:
C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12847024

MODULATION OF TMPRSS6 EXPRESSION

IPC classification:
C07H 21/04, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12779771

MULTIPLE- ANALYTE ASSAY DEVICE AND SYSTEM

IPC classification:
B01L 3/00, C12M 1/34, G01N 27/327, G01N 35/00, G01N 35/10
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12795954

BIOCATALYSTS FOR THE PREPARATION OF HYDROXY SUBSTITUTED CARBAMATES

IPC classification:
C12N 9/00, C12N 9/04, C12P 7/00, C12P 13/00, C12P 17/10
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11744148

METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF DIFFERENT ANEUPLOIDIES IN A SAMPLE

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859599

FATTY ALCOHOL FORMING ACYL REDUCTASE (FAR) VARIANTS AND METHODS OF USE

IPC classification:
C12N 1/21, C12N 9/02, C12N 15/53
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859369

PRODUCTION OF SATURATED FATTY ALCOHOLS FROM ENGINEERED MICROORGANISMS

IPC classification:
C12P 7/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12859854

AMPLIFICATION PRIMERS AND METHODS

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12859739

ENDOGLUCANASE 1B (EG1B) VARIANTS

IPC classification:
C12N 9/42
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12860563

METHODS FOR MODULATING METASTASIS-ASSOCIATED-IN-LUNG-ADENOCARCINOMA-TRANSCRIPT-1(MALAT-1) EXPRESSION

IPC classification:
C07H 21/02, C12N 15/11, A61K 38/28
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12862360

COMPOSITIONS AND METHODS FOR SAMPLE PREPARATION

IPC classification:
G01N 1/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP13741594

LOW DENSITY, HIGHLY POROUS NANO STRUCTURE

IPC classification:
B82B 1/00, B82B 3/00, C09K 11/02, A61K 49/06
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13743020

COMBINATION THERAPY COMPRISING A GROWTH HORMONE VARIANT AND AN OLIGONUCLEOTIDE TARGETED TO THE GROWTH HORMONE RECEPTOR

IPC classification:
A61P 5/08, A61K 31/7088, A61K 38/27
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13746752

MODULATION OF RNA BY REPEAT TARGETING

IPC classification:
C07H 21/04, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12776541

CELLOBIOHYDROLASE VARIANTS

IPC classification:
C12N 9/42, C12P 19/02, C12P 19/14
Applicant:
Shell Internationale Research Maatschappij B.V.
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Robert Maarten Matthezing, Shell International B.V.
Status:
EXAMINATION IN PROGRESS
EP11824373

METHOD FOR MOBILIZING STEM AND/OR PROGENITOR CELLS

IPC classification:
A61P 43/00, C07H 21/00, A61K 31/7125
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14177983

Chaperonin 10 immunosuppression

IPC classification:
A61P 37/06, A61K 38/17
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12836344

FUNGAL PROTEASES

IPC classification:
C12N 1/15, C12N 9/20, C12N 9/24, C12N 9/48, C12N 9/58, C12N 15/57, C12P 19/02, C12P 19/14, C12P 21/00, C12P 21/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13767959

COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION FOR REDUCING SEIZURE AND MODIFYING A NEURODEGENERATIVE SYNDROME

IPC classification:
C07H 21/02, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13720699

MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY

IPC classification:
A61P 13/12, A61P 35/00, A61P 43/00, C12N 15/113, A61K 31/712
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13724127

ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS

IPC classification:
C07K 14/435
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14192160

Simultaneous determination of aneuploidy and fetal fraction

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13800883

METHODS OF TREATING OVERWEIGHT AND OBESITY

IPC classification:
A61K 31/22, A61K 31/24, A61K 31/335
Agent:
Zacco Denmark A/S
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13732008

PROSTATE-SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 47/48
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13730786

ANTI-PSMA ANTIBODIES CONJUGATED TO NUCLEAR RECEPTOR LIGAND POLYPEPTIDES

IPC classification:
C07K 16/30, A61K 47/48
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13732069

ANTI-CD70 ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 47/48
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13817140

BIOREFINERY SYSTEM, METHODS AND COMPOSITIONS THEREOF

IPC classification:
C12N 1/21, C12N 15/63, C12P 7/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13823783

MODULATION OF RENIN-ANGIOTENSIN SYSTEM (RAS) RELATED DISEASES BY ANGIOTENSINOGEN

IPC classification:
C07H 21/02, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13836738

LENTIVIRAL VECTOR FOR STEM CELL GENE THERAPY OF SICKLE CELL DISEASE

IPC classification:
C12N 15/12, C12N 15/867, A61K 48/00
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13841213

SWAB INTERFACE FOR A MICROFLUIDIC DEVICE

IPC classification:
C12M 1/30, G01N 1/02, A61B 10/02
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13844924

GAS-FED FERMENTATION SYSTEMS

IPC classification:
C12M 1/107, C12M 1/38
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13847099

METHODS FOR MONITORING C9ORF72 EXPRESSION

IPC classification:
C12N 5/00, C12N 5/071, C12N 15/11, C12Q 1/68
Applicant:
Johns Hopkins University
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13846202

METHODS OF TREATING KENNEDY'S DISEASE

IPC classification:
A61K 31/7088
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13777458

METHODS FOR TREATMENT OF ALPORT SYNDROME

IPC classification:
A61P 13/12, C12N 15/113, A61K 31/7125
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13846313

METHODS FOR MODULATING C9ORF72 EXPRESSION

IPC classification:
C12N 15/11, A61K 48/00
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
University of California
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11850991

GENE DISRUPTANTS PRODUCING FATTY ACYL-COA DERIVATIVES

IPC classification:
C12N 1/00, C12N 15/00, C12P 7/62
Applicant:
Shell Internationale Research Maatschappij B.V.
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Robert Maarten Matthezing, Shell International B.V.
Status:
The patent has been granted
EP11740540

METHODS AND COMPOSITIONS USEFUL IN TREATMENT OF DISEASES OR CONDITIONS RELATED TO REPEAT EXPANSION

IPC classification:
C07H 21/04, C12N 15/11, C12N 15/113
Applicant:
Isis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13853782

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF FATTY ACID DERIVATIVES

IPC classification:
C12N 1/20, C12P 7/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13856755

PENTOSE FERMENTATION BY A RECOMBINANT MICROORGANISM

IPC classification:
C12N 1/15, C12N 1/18, C12N 9/24, C12N 9/92, C12N 15/04, C12N 15/11, C12P 7/06, C12P 19/24, C12R 1/645, C12R 1/85, C12R 1/865
Applicant:
Shell Internationale Research Maatschappij B.V.
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Robert Maarten Matthezing, Shell International B.V.
Status:
GRANT OF PATENT INTENDED
EP13864954

STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME

IPC classification:
C40B 40/04
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13864666

ENGINEERED BIOCATALYSTS AND METHODS FOR SYNTHESIZING CHIRAL AMINES

IPC classification:
C12N 9/10, C12N 15/54, C12N 15/63, C12P 13/00
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14737706

ENZYME PRODUCTION COMPOSITIONS AND METHODS

IPC classification:
C12P 7/14
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15158571

Use of adipose tissue-derived stromal stem cells in treating fistula

IPC classification:
A61P 17/02, C12N 5/077, A61K 35/36, A61L 27/38
Applicant:
Universidad Autónoma de Madrid (UAM)
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11825969

STABILIZATION OF OZONE-LABILE FLUORESCENT DYES BY THIOUREA

IPC classification:
C07C 335/04, C09B 23/06, G01N 33/58
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14740809

ENGINEERED BIOCATALYSTS USEFUL FOR CARBAPENEM SYNTHESIS

IPC classification:
C12N 1/21
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14746677

METHODS, SYSTEMS, AND SOFTWARE FOR IDENTIFYING BIO-MOLECULES WITH INTERACTING COMPONENTS

IPC classification:
G06G 7/58
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14746406

METHODS, SYSTEMS, AND SOFTWARE FOR IDENTIFYING BIO-MOLECULES USING MODELS OF MULTIPLICATIVE FORM

IPC classification:
G01N 33/50
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15175622

NONINVASIVE DIAGNOSIS OF FETAL ANEUPLOIDY BY SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14757245

ENGINEERED TRANSAMINASE POLYPEPTIDES FOR INDUSTRIAL BIOCATALYSIS

IPC classification:
C12N 15/54
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14760467

LIPID BILAYER COATED MESOPOROUS SILICA NANOPARTICLES WITH A HIGH LOADING CAPACITY FOR ONE OR MORE ANTICANCER AGENTS

IPC classification:
A61P 35/00, A61K 9/127, A61K 9/16, A61K 47/02
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Anton Hutter, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP14768515

HIGH-SPEED ON DEMAND MICROFLUIDIC DROPLET GENERATION AND MANIPULATION

IPC classification:
C12M 1/42, G01N 33/48, G01N 35/08
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14717959

GENERATING CELL-FREE DNA LIBRARIES DIRECTLY FROM BLOOD

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14768844

NUCLEIC ACID CONTROL PANELS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14772979

SYSTEMS AND METHODS FOR ISOLATING NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14768315

PHOTOCLEAVABLE DEOXYNUCLEOTIDES WITH HIGH-RESOLUTION CONTROL OF DEPROTECTION KINETICS

IPC classification:
C07H 21/04, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14769128

NUCLEOTIDE ANALOGS FOR SEQUENCING

IPC classification:
C07H 19/00, C07H 21/04, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14769114

BERAPROST ISOMER AS AGENT FOR THE TREATMENT OF VIRAL INFECTION

IPC classification:
A61P 31/12, A61P 31/16, A61K 31/343, A61K 31/5585
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP14773416

MULTIPLEX METHYLATION-SPECIFIC AMPLIFICATION SYSTEMS AND METHODS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11740542

SELECTIVE REDUCTION OF ALLELIC VARIANTS

IPC classification:
C12N 15/113
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14748994

CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE

IPC classification:
A61P 31/12, A61K 35/00
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14791480

USE OF ANTI-CD47 AGENTS TO ENHANCE IMMUNIZATION

IPC classification:
C12N 5/10
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14762452

SDF-1 DELIVERY FOR TREATING ISCHEMIC TISSUE

IPC classification:
C07H 21/04, C12N 15/00, A61K 48/00
Applicant:
The Cleveland Clinic Foundation
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14791187

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION

IPC classification:
C07K 14/775, C12N 15/113, A61K 48/00
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14768797

METHODS FOR ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS

IPC classification:
C07K 16/28
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15177512

METHODS FOR MODULATING LIPOPROTEIN AND CHOLESTEROL LEVELS IN HUMANS

IPC classification:
A61P 3/06, C12N 15/11, A61K 48/00
Applicant:
Genzyme Corporation
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15192408

MODULATION OF FACTOR 7 EXPRESSION

IPC classification:
A61P 7/02, A61P 35/00, C12N 15/113, A61K 31/7088
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15195673

NON-INVASIVE FETAL GENETIC SCREENING BY DIGITAL ANALYSIS

IPC classification:
C12P 19/34, C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15189401

MODULATION OF APOLIPOPROTEIN C-III EXPRESSION

IPC classification:
A61K 31/00
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15196275

HLA-RESTRICTED, PEPTIDE-SPECIFIC ANTIGEN BINDING PROTEINS

IPC classification:
C07K 16/08, C07K 16/18, C07K 16/28, A61K 39/395
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15181244

METHODS FOR DETERMINING FRACTION OF FETAL NUCLEIC ACIDS IN MATERNAL SAMPLES

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14739612

METHOD FOR DETERMINING COPY NUMBER VARIATIONS IN SEX CHROMOSOMES

IPC classification:
C12Q 1/68, G06F 19/24
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14737468

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF LACTATE FROM C1 COMPOUNDS USING LACTATE DEHYDROGENASE TRANSFORMANTS

IPC classification:
C12N 9/04, C12P 7/56
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14820178

METHOD FOR THE PURIFICATION OF TARGETED NUCLEIC ACIDS FROM BACKGROUND NUCLEIC ACIDS

IPC classification:
C12N 15/10
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15199731

METHOD OF SYNTHESIZING POLYNUCLEOTIDE VARIANTS

IPC classification:
C07H 21/00, C12N 15/10, C12N 15/11, C12Q 1/68, C40B 40/06, C40B 50/06
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11829931

USE OF AN ENDOGENOUS 2-MICRON YEAST PLASMID FOR GENE OVER EXPRESSION

IPC classification:
C12N 15/66, C12N 15/81
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14772484

PRODUCTION OF 1,6-HEXANEDIOL FROM ADIPIC ACID

IPC classification:
B01J 23/42, C07C 29/149
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14761937

MASSIVELY PARALLEL SINGLE CELL ANALYSIS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14839126

METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES

IPC classification:
A61P 19/00, A61P 19/02, C07K 7/06, C07K 7/08, C12N 5/077, C12N 5/10, C12N 15/11, A61K 35/32, A61K 38/17, A61K 47/36
Applicant:
McGill University - The Royal Institution for the Advancement of Learning
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15198767

MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS

IPC classification:
C07K 16/28, C07K 16/30, C12N 5/00, C12N 5/09, C12Q 1/68, G01N 33/50, G01N 33/574, A61K 39/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11797388

TREATMENT OF PROLIFERATIVE DISEASES

IPC classification:
A61P 35/00, G01N 33/50, A61K 38/16
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14845184

MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE

IPC classification:
A61P 9/10
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14781426

AUTOMATED SCREENING OF ENZYME VARIANTS

IPC classification:
G06F 19/00, G06F 19/16
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14786396

STRUCTURE BASED PREDICTIVE MODELING

IPC classification:
G06F 19/16
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP16160470

METHODS FOR MANIPULATING PHAGOCYTOSIS MEDIATED BY CD47

IPC classification:
C07K 16/18, C07K 16/28, C07K 16/30, C07K 16/46, A61K 39/00, A61K 39/395, A61K 47/48
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14786757

METHODS AND SYSTEMS FOR DIGITALLY COUNTING FEATURES ON ARRAYS

IPC classification:
G01N 21/27, G01N 21/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP16160476

METHODS FOR MANIPULATING PHAGOCYTOSIS MEDIATED BY CD47

IPC classification:
C07K 16/18, C07K 16/28, C07K 16/30, C07K 16/46, A61K 39/00, A61K 39/395, A61K 47/48
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14854442

METHODS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT

IPC classification:
C07H 21/04, C12N 15/11, A61K 38/00
Applicant:
University of California
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14854291

COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT

IPC classification:
C07H 21/04, C12N 15/11
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14854819

NUCLEOSIDE SUPPLEMENTATION TO PROMOTE CELLULAR FUNCTION, GENETIC STABILITY AND REGENERATIVE APPLICATIONS

IPC classification:
C12N 5/02, C12N 5/074
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14796611

METHOD FOR IMPROVING THE SENSITIVITY OF DETECTION IN DETERMINING COPY NUMBER VARIATIONS

IPC classification:
G06F 19/20, G06F 19/22
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14802966

MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY

IPC classification:
C12N 15/113
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11778262

BIOCATALYSTS FOR EZETIMIBE SYNTHESIS

IPC classification:
C07K 1/00, A61K 38/16
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11761888

MACROCYCLIC LACTONE RESISTANCE MARKER FOR DIROFILARIA IMMITIS

IPC classification:
C07H 21/04, C07K 14/435, C12N 15/12, C12Q 1/68
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14860658

TARGETED SCREENING FOR MUTATIONS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP12183946

Noninvasive diagnosis of fetal aneuploidy by sequencing

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
PATENT GRANTED
EP14862555

ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS

IPC classification:
C07K 14/305
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11838704

COMPOSITIONS AND METHODS FOR PRODUCTION OF FERMENTABLE SUGARS

IPC classification:
C12N 1/15, C12N 1/22, C12N 9/04, C12N 9/42, C12P 7/10, C12P 19/02, C12P 19/12, C12P 19/14, C13K 1/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14867191

COMPOSITIONS AND METHODS FOR REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS

IPC classification:
A61P 3/04, A61K 31/137, A61K 31/485
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16158103

RESOLVING GENOME FRACTIONS USING POLYMORPHISM COUNTS

IPC classification:
C12Q 1/68, G06F 19/18, G06F 19/22, G06F 19/24
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14874081

MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION

IPC classification:
C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15737349

MICROORGANISMS FOR THE ENHANCED PRODUCTION OF AMINO ACIDS AND RELATED METHODS

IPC classification:
C12N 1/21, C12P 13/04, C12P 13/08, C12P 13/12, C12P 13/22
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15737403

CARBOHYDRATE-ENRICHED RECOMBINANT MICROORGANISMS

IPC classification:
C12N 1/21, C12N 9/88, A23K 50/00, A23K 10/40
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16163920

MODIFIED LEPTIN POLYPEPTIDES AND THEIR USES

IPC classification:
C07H 21/04, C07K 14/00, C07K 14/575, C12P 21/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15746681

CELL MODULATION NANOCOMPOSITION, AND METHODS OF USE

IPC classification:
B82B 1/00, C07K 14/705, C07K 14/725, C12N 5/02, C12N 5/0783, G01N 33/58
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15711627

DISPOSABLE, INTEGRATED MICROFLUIDIC CARTRIDGE AND METHODS OF MAKING AND USING SAME

IPC classification:
B01L 3/00, B01L 7/00
Applicant:
Illumina, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15764889

GENOME EDITING WITHOUT NUCLEASES

IPC classification:
C12N 15/85
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15769138

EFFICIENT DELIVERY OF LARGE CARGOS INTO CELLS ON A POROUS SUBSTRATE

IPC classification:
C12N 1/15, C12N 1/19, C12N 5/071, C12N 15/87
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16179626

COMPOSITION AND METHODS FOR INCREASING INSULIN SENSITIVITY

IPC classification:
A61P 3/10, A61K 31/00, A61K 31/135, A61K 31/138, A61K 31/423, A61K 31/4525, A61K 31/485, A61K 31/55, A61K 31/551, A61K 31/7048, A61K 45/06
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16194186

COMPOSITIONS AND METHODS FOR SAMPLE PREPARATION

IPC classification:
C12N 15/10, G01N 1/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15726809

METHODS FOR BIOLOGICAL PRODUCTION OF VERY LONG CARBON CHAIN COMPOUNDS

IPC classification:
C12N 1/21, C12P 7/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15793647

METHOD TO CONCENTRATE APOA-I MIMETIC PEPTIDES TRANSGENICALLY EXPRESSED IN PLANTS

IPC classification:
A61P 35/00, C07K 1/14, C07K 7/08, C07K 14/775, A61K 38/00, A61K 38/10
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15779558

ENGINEERED TYROSINE AMMONIA LYASE

IPC classification:
C12N 9/88, A61K 38/51
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15728356

DETECTING FETAL SUB-CHROMOSOMAL ANEUPLOIDIES AND COPY NUMBER VARIATIONS

IPC classification:
C12Q 1/68, G06F 19/20
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16199980

CELLS FOR USE IN A METHOD FOR TREATING INFLAMMATORY DISORDERS

IPC classification:
C12N 5/077, C12N 5/0775, C12N 5/0783
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15742101

MESENCHYMAL STROMAL CELLS FOR TREATING RHEUMATOID ARTHRITIS

IPC classification:
A61P 9/02, A61K 35/28
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15742102

MESENCHYMAL STROMAL CELLS FOR TREATING SEPSIS

IPC classification:
A61P 31/00, A61K 35/28
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15818953

NOVEL P450-BM3 VARIANTS WITH IMPROVED ACTIVITY

IPC classification:
C07H 21/04, C07K 14/00, C12N 1/20, C12N 9/02, C12N 15/00
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16188163

COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES

IPC classification:
A61P 35/00, C07D 207/325, C07D 401/12, C07D 417/12, C07K 5/02, C07K 5/06, C07K 16/28, A61K 31/337, A61K 31/427, A61K 39/00, A61K 39/395
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP16194174

SAMPLE PREPARATION METHODS

IPC classification:
C07H 1/08, C12N 15/10, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15750573

TARGETING MICRORNAS FOR METABOLIC DISORDERS

IPC classification:
C07H 21/00, C12N 15/113, A61K 31/712
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP17154000

QUANTITATING HIGH TITER SAMPLES BY DIGITAL PCR

IPC classification:
C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15831906

MULTIFUNCTIONAL OLIGONUCLEOTIDES

IPC classification:
C12Q 1/68, C40B 30/04, C40B 40/06
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15832024

LIBRARY GENERATION FOR NEXT-GENERATION SEQUENCING

IPC classification:
C12N 15/10, C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16200105

HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47

IPC classification:
C07K 16/28, C07K 16/46, C12N 5/07, C12N 5/16, C12P 21/08, G01N 33/68, A61K 39/395
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15834442

APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1

IPC classification:
A61P 25/28, C07C 219/10, C07C 219/14, A61K 31/16, A61K 31/165
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15836264

METHODS OF FABRICATING A MULTI-ELECTRODE ARRAY FOR SPINAL CORD EPIDURAL STIMULATION

IPC classification:
A61N 1/05, A61N 1/18
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15836927

MULTI-ELECTRODE ARRAY FOR SPINAL CORD EPIDURAL STIMULATION

IPC classification:
A61N 1/04, A61N 1/05
Applicant:
University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15835482

ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING

IPC classification:
C07K 16/30, C12Q 1/68, A61K 39/395
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16201269

IMPROVED LOV-D ACYLTRANSFERASE MEDIATED ACYLATION

IPC classification:
C07K 14/00, C12N 9/10, C12P 7/00
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
The application has been published
EP15771527

DETECTING REPEAT EXPANSIONS WITH SHORT READ SEQUENCING DATA

IPC classification:
G06F 19/18
Applicant:
Illumina Cambridge Ltd
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15842185

ANTISENSE COMPOUNDS AND USES THEREOF

IPC classification:
C12N 15/00, C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15841383

TARGETING ANEURYSM DISEASE BY MODULATING PHAGOCYTOSIS PATHWAYS

IPC classification:
A61P 9/10
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15841893

SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS

IPC classification:
C07K 1/04, C40B 60/14
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15842825

ANTISENSE COMPOUNDS AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16205580

USING CELL-FREE DNA FRAGMENT SIZE TO DETERMINE COPY NUMBER VARIATIONS

IPC classification:
C12Q 1/68, G06F 19/00, G06F 19/18, G06F 19/22, G06F 19/24
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP16203872

SELECTIVE REDUCTION OF ALLELIC VARIANTS

IPC classification:
C07H 21/04, C12N 15/11, C12Q 1/68
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
The application has been published
EP15852776

ENRICHMENT OF SMALL NUCLEIC ACIDS

IPC classification:
B01D 15/34
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15852949

IMPROVED CLOTTING COMPOSITION

IPC classification:
A61P 7/00, C12Q 1/56, G01N 33/49, G01N 33/86, A61K 38/36
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15852981

SWAB PORT FOR MICROFLUIDIC DEVICES

IPC classification:
B01L 3/14, B65D 75/36, B65D 81/32, G01N 1/10, A61F 13/38
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15853503

COMPOSITIONS AND METHODS FOR INDUCING PHAGOCYTOSIS OF MHC CLASS I POSITIVE CELLS AND COUNTERING ANTI-CD47/SIRPA RESISTANCE

IPC classification:
C12N 5/078, C12N 5/0786
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15852699

BACTERIAL EPIGENOMIC ANALYSIS

IPC classification:
C12Q 1/04, C12Q 1/68, G06F 19/18
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15853242

APPARATUSES FOR STERILELY DELIVERING FLUID

IPC classification:
C12M 1/30, C12Q 1/24, G01N 1/28, A61M 39/04
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15853244

NUCLEIC ACID AMPLIFICATION APPARATUS AND SYSTEM

IPC classification:
B01L 7/00, B01L 99/00, C12P 19/34
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15859151

HYBRIDIZATION PROBES AND METHODS

IPC classification:
C12N 15/10, C12N 15/11
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17160932

ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS FOR USE IN TREATING REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE

IPC classification:
A61P 1/00, A61K 35/28
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP15795157

THERAPEUTIC HOMODIMER AND USES THEREOF

IPC classification:
A61P 3/10, A61K 38/08
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17156985

INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY

IPC classification:
A61P 3/04, A61K 31/137, A61K 31/485
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
The application has been published
EP15864252

ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS

IPC classification:
C12N 9/08
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15862653

BIOSYNTHETIC PRODUCTION OF CAFFEINE

IPC classification:
A23F 5/00
Applicant:
The Coca-Cola Company
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15874075

HUMAN ALPHA-GALACTOSIDASE VARIANTS

IPC classification:
C07K 14/47, C12N 9/24, C12N 15/56, A61K 38/47
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16740872

DEVICES AND SYSTEMS FOR MOLECULAR BARCODING OF NUCLEIC ACID TARGETS IN SINGLE CELLS

IPC classification:
B01L 3/02, G01N 35/08, G01N 35/10
Applicant:
Becton Dickinson and Company
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16740762

MACROPHAGES EAT CANCER CELLS USING THEIR OWN CALRETICULIN AS A GUIDE

IPC classification:
A61P 35/00, A61K 31/33, A61K 31/70, A61K 39/00, A61K 39/395
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17168021

SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT

IPC classification:
C07K 16/28, A01N 63/00, A61K 39/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
The application has been published

Please Sign in to use this feature